z-logo
open-access-imgOpen Access
Low-Dose Naltrexone Treatment of Familial Benign Pemphigus (Hailey-Hailey Disease)
Author(s) -
Omer Ibrahim,
Sara Hogan,
Alok Vij,
Anthony P. Fernandez
Publication year - 2017
Publication title -
jama dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.128
H-Index - 166
eISSN - 2168-6084
pISSN - 2168-6068
DOI - 10.1001/jamadermatol.2017.2445
Subject(s) - medicine , hailey–hailey disease , pemphigus , dermatology , naltrexone , opioid , receptor
Familial benign pemphigus, or Hailey-Hailey disease (HHD), is a rare and debilitating genetic dermatosis characterized by chronic, recurrent vesicles, erosions, and maceration in flexural areas. Despite the reported therapeutic modalities, such as topical and systemic corticosteroids, systemic immunomodulators, topical and systemic retinoids, and laser, HHD can still be markedly difficult to control.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom